(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to a kidney and bladder cancers poster session. Dr. Michal Sternschuss presented an analysis of outcomes ...

Prognostic Value of Perioperative Circulating Tumor DNA in Pure Urothelial Carcinoma and Histological Subtypes of Bladder Cancer - Beyond the Abstract ...

To evaluate the hypothesis that infectious adverse events following prostatic artery embolization (PAE) are comparable to those following other treatment options for benign prostatic hyperplasia (BPH) ...

Comprehensive Analysis of microRNA Expression Provides Mechanistic Insights into Transcriptomic Alteration in Primary and Metastatic Testicular Germ Cell Tumors - Beyond the Abstract ...

(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) annual meeting featured a session on prostate cancer, and a presentation by Dr. Daniel Petrylak discussing initial results of a ...

Dosimetric Analysis of Post-Radiotherapy Sexual Dysfunction in Patients Receiving Definitive Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer: A Secondary Analysis of MIRAGE - Beyond the ...

Intermittent catheterization (IC) is the preferred procedure for individuals with incomplete bladder emptying from non-neurogenic or neurogenic lower urinary tract dysfunction (NLUTD). IC is now ...

A Randomized Controlled Pilot Trial to Assess the Effectiveness of a Specially Formulated Food Supplement and Pelvic Floor Muscle Training in Women with Stress-Predominant Urinary Incontinence - ...

(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to a kidney and bladder cancers poster session. Dr. David Cade presented LUTEON, an ongoing phase III trial ...

Management of Asymptomatic Bacteriuria and Urinary Tract Infections in Patients with Neurogenic Bladder and Factors Associated with Inappropriate Diagnosis and Treatment - Beyond the Abstract ...

(UroToday.com) The 2026 ASCO annual meeting featured an oral abstract kidney cancer session and a presentation by Dr. Junru Chen discussing a prospective, multi-center, phase Ib/II trial of first line ...

(UroToday.com) The 2024 European Association of Urology (EAU) annual meeting featured a plenary session on personalized approaches in high-risk and metastatic prostate cancer, and a presentation by Dr ...